Содержание
- 2. Peptic Ulcer 10% population affected Gastric ulcer in elderly 5-6th decade Duodenal ulcer in adults 4th
- 3. Duodenal Ulcer Proximal duodenum 1 - 2 cm of pylorus ▲ acid Distal duodenum = ZE
- 4. Type 1 Gastric Ulcer most common (among gastric Ulcers) proximal antrum ↓ mucosal defense ↓ acid
- 5. Type II Gastric Ulcer Secondary to DU + pyloric stenosis
- 6. Type III Gastric Ulcer Prepyloric and pyloric canal ulcer acid ▲ common etiology with DU
- 7. Incidence etiology CP Investigations DD Rx
- 8. Pathogenesis Imbalance of acid-pepsin and mucosal defence H. pylori infection NSAID ZE Syndrome Type A personality
- 9. H.pylori 95% - duodenal ulcer 80% - gastric ulcer ↓ mucosal resistance hydrophobicity eradication reduces ulcer
- 10. NSAID Suppress prostaglandins prostaglandin ► ↓ acid secretion ↑ ▲ mucosal blood flow ↑ mucus &
- 11. A/ DU NSAIDs Acid hypersecretion Rapid gastric emptying Impaired acid disposal Smoking
- 12. Duodenal Ulcer Increased secretion of acid More rapid gastric emptying Decreased prostaglandin Chronic duodenitis with H.pylori
- 13. Gastric Ulcer H.pylori NSAIDs Duodenogastric reflux Impaired gastric mucosal defense
- 14. Gastric Ulcer Acid secretion - normal to low Reflux of duodenal contents → gastritis → ulcer
- 15. Clinical Presentation Duodenal Ulcer pain relieved by food or alkali pain several hours after meal Gastric
- 16. Periodic chronic recurrent pain Nausea & vomiting Weight loss Epigastric tenderness
- 17. Investigations Endoscopy 90% sensitivity must in all pts. with severe pain excludes malignancy biopsy can be
- 18. Investigations Barium Meal double (air) contrast 90% sensitivity
- 19. H Pylori detection: Breath test Blood test Tissue test
- 20. Treatment Stop smoking, NSAIDs Stop alcohol Antacids - acid neutralisation H2 receptor antagonist -Ranitidine - secretion
- 21. H+ pump inhibition - H+/K+ase inhibition - Omeprazole Anticholinergic - secretory inhibition Prostaglandin - Misoprostol -
- 22. Proton Pump Blockers Omeperazole Eso-meperazole Rabi-meperazole
- 23. Sucralfate - protective coating Colloidal Bismuth eradicate H.pylori protective coating Antibiotics - H.pylori Kit for H
- 24. H2 Receptor Antagonists On parietal cells Decrease basal & stimulated acid secretion Pepsin output decreased Decreased
- 25. Treatment - Duodenal Ulcer 95% control - medical Rx Surgery-Outdated, Obsolete Omeprazole better thanRanitidine Ulcer heels
- 26. Indications for surgery =Compl Hemorrhage Obstruction Perforation Intractability of pain Intractable pain ► HSV / TV
- 27. H2 blockers heals 75% DU in 4 weeks H/K proton pump inhibitor better results ulcer may
- 28. Indication of surgery in hemorrhage bleeding of > than 6 units recurrent bleed after endoscopic control
- 29. Perforation - simple closure with omental patch -Graham’s patch definitive surgery HSV TV + pyloroplasty parietal
- 30. Treatment GU Omeprazole, H2 receptor antagonist - 8 weeks if pain not relieved by 2 weeks
- 31. Type I - Distal Gastrectomy with vagotomy + G-D or GJ proximal ulcer- total gastrectomy parietal
- 32. Hemorrhage Hemorrhage - potential cause of death 15 -20% gross bleeding erosion of duodenal ulcer into
- 33. Perforation In 5-10% of cases pneumo-peritoneum in 75% cases peritonitis, pain, ileus leukocytosis, hypovolumia, IIIrd space
- 34. Obstruction Chronic ulcer disease with edema and scarring in 5% cases of DU nausea, vomiting, abdominal
- 35. Obstruction Endoscopy Ba study Scintigraphy Rx V + G-J / G-D
- 37. Скачать презентацию